Phase 3 study of nilotinib vs imatinib in Chinese patients with newly diagnosed chronic myeloid leukemia in chronic phase: ENESTchina
Articolo
Data di Pubblicazione:
2015
Tipologia CRIS:
03A-Articolo su Rivista
Keywords:
Adolescent; Adult; Aged; Antineoplastic Agents; Benzamides; China; Female; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Chronic-Phase; Male; Middle Aged; Neoadjuvant Therapy; Piperazines; Pyrimidines; Treatment Outcome; Young Adult; Hematology; Biochemistry; Cell Biology; Immunology
Elenco autori:
Wang, Jianxiang; Shen, Zhi-Xiang; Saglio, Giuseppe; Jin, Jie; Huang, He; Hu, Yu; Du, Xin; Li, Jianyong; Meng, Fanyi; Zhu, Huanling; Hu, Jianda; Wang, Jianmin; Hou, Ming; Hertle, Sabine; Menssen, Hans D.; Ortmann, Christine-Elke; Tribouley, Catherine; Yuan, Ye; Baccarani, Michele; Huang, Xiaojun
Link alla scheda completa:
Pubblicato in: